CTOs on the Move

ARI Technologies

www.aritechnologies.com

 
ARI Technologies is a Kent, WA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Captive Audience Marketing

Captive Audience Marketing is a Riverside, CA-based company in the Business Services sector.

Foothills Title

Foothills Title Services, Inc. is a real estate title company serving Tennessee and Georgia since 1997. They are committed to making the buying process smooth for all parties involved.

Regenerative Health 360

The Future of Medicine is Here and Now!

Serenity

Serenity is the only network that allows aging service providers, older adults, and their loved ones to "care together." Our web, mobile and smart assistant products power the network to enable real-time, HIPAA-compliant communication, collaboration, and education. Providers and communities increase revenue and lower expenses, while older adults get better care and their families have greater peace of mind.

Metrodora Institute

Metrodora Institute is the first medical and research center dedicated to advancing care and accelerating cures for people living with neuroimmune axis disorders. Our state-of-the-art, multidisciplinary institute brings together world-class clinicians, scientists, and technologists under one roof – to maximize the impact of scientific discovery and rapidly translate research into better human health outcomes. Comprehensive clinical programs integrate neurology, immunology, and gastroenterology care with genomics, pain management, comprehensive rehabilitation programs, as well as nutritional and neurocognitive therapies to provide personalized, patient-centered care. The Metrodora Model is a new blueprint for healthcare that breaks barriers between medical specialties and embeds scientific research and discovery directly in the patient care process. Together, we are leading the next frontier of science and medicine. Join our mission to accelerate the path to cures for hundreds of millions of people living with neuroimmune axis disorders.